First Light Asset Management, LLC Pliant Therapeutics, Inc. Transaction History
First Light Asset Management, LLC
- $1.02 Billion
- Q4 2024
A detailed history of First Light Asset Management, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, First Light Asset Management, LLC holds 1,681,110 shares of PLRX stock, worth $5.11 Million. This represents 2.16% of its overall portfolio holdings.
Number of Shares
1,681,110
Previous 2,575,546
34.73%
Holding current value
$5.11 Million
Previous $28.9 Million
23.31%
% of portfolio
2.16%
Previous 2.52%
Shares
12 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
65.8MCall Options Held
230KPut Options Held
746K-
Deep Track Capital, LP Greenwich, CT5.97MShares$18.2 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$15.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$14.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$9.82 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$9.72 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $148M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...